AKBA vs BXP · rev $160.2M vs rev $3.48B
Akebia Ther (AKBA) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Latest reported AKBA revenue for 2024-12-31 was $160.2M. Net income was -$69.4M. Revenue was down 17.7% from 2023-12-31 to 2024-12-31. AKBA currently screens at market cap $260.1M.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
AKBA currently screens at market cap $260.1M. BXP currently screens at market cap $12.12B.
Not investment advice. Open the AKBA and BXP stock pages for the full models.
Not investment advice.